These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37974107)

  • 41. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma.
    Wang Y; Zhang G; Wang R
    Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.
    Zhang P; Pei S; Gong Z; Feng Y; Zhang X; Yang F; Wang W
    Front Immunol; 2023; 14():1115272. PubMed ID: 36776843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis.
    Wang X; Chen J; Li C; Liu Y; Chen S; Lv F; Lan K; He W; Zhu H; Xu L; Ma K; Guo H
    PeerJ; 2024; 12():e17545. PubMed ID: 38938612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
    Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
    Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.
    Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J
    Front Immunol; 2022; 13():1034992. PubMed ID: 36524130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma.
    Wang Y; Huang X; Fan H; Xu Y; Qi Z; Zhang Y; Huang Y
    Aging (Albany NY); 2023 May; 15(10):4202-4235. PubMed ID: 37199651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma.
    Lin S; Zhou S; Han X; Yang Y; Zhou H; Chang X; Zhou Y; Ding Y; Lin H; Hu Q
    Aging (Albany NY); 2023 Oct; 15(20):11508-11531. PubMed ID: 37878007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma.
    Li R; Tong R; Zhang JL; Zhang Z; Deng M; Hou G
    J Cancer Res Clin Oncol; 2024 May; 150(5):246. PubMed ID: 38722401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting lung adenocarcinoma prognosis, immune escape, and pharmacomic profile from arginine and proline-related genes.
    Wang Z; Zhang J; Shi S; Ma H; Wang D; Zuo C; Zhang Q; Lian C
    Sci Rep; 2023 Sep; 13(1):15198. PubMed ID: 37709932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.
    Yu Q; Zhao L; Yan XX; Li Y; Chen XY; Hu XH; Bu Q; Lv XP
    World J Surg Oncol; 2022 Jun; 20(1):183. PubMed ID: 35668494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Inflamm Res; 2024 May; 73(5):841-866. PubMed ID: 38507067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated bioinformatics analysis of nucleotide metabolism based molecular subtyping and biomarkers in lung adenocarcinoma.
    Luo D; Wang H; Zeng Z; Chen J; Wang H
    Front Immunol; 2024; 15():1430171. PubMed ID: 39148731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.